Five-grass-pollen sublingual immunotherapy tablet for the treatment of grass-pollen-induced allergic rhinoconjunctivitis: 5 years of experience
Authors:
- Ulrich WahnUWUlrich Wahn
- Friedrich HorakFHFriedrich Horak
- Linda S CoxLCLinda S Cox
- 26 August 2014
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Clinical Immunology
- Vol. 10 (10) , 1309-1324
Abstract
Oralair(®) (OA) (Stallergenes, Antony, France) is a unique pre- and co-seasonal 5-grass-pollen sublingual immunotherapy tablet launched in 2008, and now approved in 31 countries worldwide for the treatment of grass-pollen allergic rhinitis and rhinoconjunctivitis. OA is the first oral treatment with a consistent, well-balanced allergen extract that mimics natural exposure and sensitization. A wealth of data exists from over 5 years of clinical and real-world experience demonstrating the efficacy and safety of OA for grass-pollen-allergy treatment. OA is highly effective from the first pollen season in all patient subgroups, including children and those with comorbid mild asthma, irrespective of sensitization status and symptom severity. OA also has sustained long-term benefits for symptom control and quality of life. This article provides an overview of the pharmacodynamics and pharmacology of OA; its efficacy, safety, tolerability and cost-effectiveness for the treatment of allergic rhinitis and rhinoconjunctivitis and its role in clinical practice.Keywords
This publication has 47 references indexed in Scilit:
- Burden of allergic rhinitis: Allergies in America, Latin America, and Asia-Pacific adult surveysAllergy and Asthma Proceedings, 2012
- Chapter 5: Allergic rhinitisAllergy and Asthma Proceedings, 2012
- The burden of allergic rhinitis and asthmaTherapeutic Advances in Respiratory Disease, 2011
- Allergic rhinitis in the child and associated comorbiditiesPediatric Allergy and Immunology, 2010
- The prevalence of nasal symptoms attributed to allergies in the United States: Findings from the burden of rhinitis in an America surveyAllergy and Asthma Proceedings, 2008
- The diagnosis and management of rhinitis: An updated practice parameterJournal of Allergy and Clinical Immunology, 2008
- Specific Immunotherapy for Common Grass Pollen Allergies: Pertinence of a Five Grass Pollen VaccineInternational Archives of Allergy and Immunology, 2008
- Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*Allergy, 2008
- Sexual dysfunction in patients with allergic rhinoconjunctivitisAnnals of Allergy, Asthma & Immunology, 2005
- Allergic Rhinitis and Its Impact on AsthmaJournal of Allergy and Clinical Immunology, 2001